Baxter International Inc (NYSE:BAX)
$ 33.9 -0.1 (-0.29%) Market Cap: 17.27 Bil Enterprise Value: 28.47 Bil PE Ratio: 6.52 PB Ratio: 2.11 GF Score: 79/100

Baxter International Inc at Evercore HealthCONx Conference Transcript

Dec 04, 2019 / 03:15PM GMT
Release Date Price: $82.43 (+1.75%)
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD

Okay. We'll get started. Thanks, everyone, for joining us this morning. I'm Vijay Kumar, the device and life science tools analyst at Evercore. Very happy to have with us Baxter, representing the company, we have Jay Saccaro, the CFO; and from the IR team, we have Clare Trachtman. Thank you, guys, for coming.

Questions & Answers

Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - MD

Maybe Jay, this has been a little bit of an odd year for Baxter. When you look at the last few years, the focus always was on operational excellence. Phenomenal job that the company has done, executing on the margin front. And I feel like the 3Q with the accounting audit, I know you're limited in what you can or cannot say on that front.

But I think on the call, 3Q call, investors were trying on their ability to deploy capital as being tied to the accounting audit. And given you just did the Seprafilm acquisition, maybe you just provide some context on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot